2B70.F iShares NASDAQ US Biotechnology UCITS ETF

ETF Healthcare Equity BlackRock Asset Management Ireland - ETF Frankfurt Exchange
- EUR
No recent price
Total assets
1.29B
Expense ratio
0.36%
Dividend yield
0.88%
1-year return
+41.47%
Holdings
10
Since
2017

Fund data as reported by the issuer, updated Nov 11, 2026. Total assets are in the fund's base currency.

What does 2B70.F invest in?

Tracks Morningstar Gbl Biotechnology NR USD
  • Mostly US stocks (93.4%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (97.4%)
  • Top 3 holdings: 25.7% of the fund

Asset allocation

  • US stocks 93.4%
  • Non-US stocks 5.4%
  • Cash 0.2%

Top holdings

All holdings, sectors and regions

iShares NASDAQ US Biotechnology UCITS ETF performance

Sharpe ratio 0.92
This year
+32.42%
1 year
+41.47%
3 years
+24.90%
5 years
+9.43%

Volatility 18.4% over 1 year and 19.5% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

2B70.F price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About iShares NASDAQ US Biotechnology UCITS ETF

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

Full fund profile